OTCMWCUI
Market cap57kUSD
Dec 24, Last price
0.00USD
1D
25.00%
1Q
150.00%
Jan 2017
-99.73%
IPO
-99.89%
Name
Wellness Center USA Inc
Chart & Performance
P/E
—
P/S
0.09
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
10.29%
Rev. gr., 5y
19.39%
Revenues
662k
+14.45%
Net income
-753k
L-32.19%
CFO
-549k
L-36.50%
Profile
Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tuscon, Arizona.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
| Income | |||||||||
Revenues | 662 14.45% | 578 140.89% | |||||||
Cost of revenue | 74 | 69 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 588 | 509 | |||||||
NOPBT Margin | 88.81% | 88.02% | |||||||
Operating Taxes | (195) | (353) | |||||||
Tax Rate | |||||||||
NOPAT | 782 | 862 | |||||||
Net income | (753) -32.19% | (1,110) 17.83% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 3,737 | 3,210 | |||||||
Long-term debt | 305 | 305 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | (1) | (1) | |||||||
Net debt | 3,985 | 3,452 | |||||||
| Cash flow | |||||||||
Cash from operating activities | (549) | (865) | |||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | 542 | 896 | |||||||
FCF | 996 | 930 | |||||||
| Balance | |||||||||
Cash | 56 | 63 | |||||||
Long term investments | |||||||||
Excess cash | 23 | 34 | |||||||
Stockholders' equity | (30,996) | (30,054) | |||||||
Invested Capital | 30,096 | 29,368 | |||||||
ROIC | 2.63% | 3.01% | |||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 140,375 | 131,447 | |||||||
Price | 0.02 -41.71% | ||||||||
Market cap | 2,958 -36.65% | ||||||||
EV | 5,717 | ||||||||
EBITDA | 588 | 509 | |||||||
EV/EBITDA | 11.24 | ||||||||
Interest | 241 | 208 | |||||||
Interest/NOPBT | 40.97% | 40.87% | |||||||